Amphastar Pharma (AMPH) Tops Q3 EPS by 5c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $57.9 million versus the consensus estimate of $57.2 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• BlockchainK2 plans private placement to raise up to $130,000
• AI and earnings keep driving markets as focus shifts to Trump-Xi summit